共 21 条
[1]
Newell-Price J(1998)The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states Endocr. Rev. 19 647-672
[2]
Reincke M(2000)Subclinical Cushing's syndrome Endocrinol. Metab. Clin. North Am. 29 43-56
[3]
Nieman LK(2019)Hypertension and cardiovascular mortality in patients with Cushing syndrome Endocrinol. Metab. Clin. North Am. 48 717-725
[4]
Mazziotti G(2011)Diabetes in Cushing syndrome: Basic and clinical aspects Trends Endocrinol. Metab. 22 499-506
[5]
Gazzaruso C(2014)Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: A 15-year retrospective study Lancet. Diabetes Endocrinol. 2 396-405
[6]
Giustina A(2016)Cushing's syndrome: Screening and diagnosis High Blood Press Cardiovasc. Prev. 23 209-215
[7]
Di Dalmazi G(2016)Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal Tumors Eur. J. Endocrinol. 175 G1-g34
[8]
Ceccato F(2021)Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: A cohort study Ann. Intern. Med. 174 1041-1049
[9]
Boscaro M(2019)Primary aldosteronism diagnosis and management: A clinical approach Endocrinol. Metab. Clin. North. Am. 48 681-700
[10]
Fassnacht M(2016)The management of primary aldosteronism: case detection, diagnosis, and treatment: An endocrine society clinical practice guideline J. Clin. Endocrinol. Metab. 101 1889-1916